• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Jan. 2

Aurobindo Pharma Ltd (APL) has announced that it has received two more approvals from the US Food and Drug Administration (USFDA) for Bisoprolol 5 mg, 10 mg & Amoxicillin oral suspension 200 mg/5ml, and 400mg/5ml.

This is the company's 34th & 35th generic approval given by the US FDA respectively.

Amoxicillin oral suspension is a Beta-lactam antibiotic used often in treating respiratory infections. GSK is the inventor of this antibiotic and is marketed under the brand name Amoxil.

Bisoprolol, on the other hand is a beta 1-selective (cardioselective) adrenoceptor-blocking agent. It belongs to the group called Beta-blockers. Bisoprolol tablets are employed in managing cardiovascular diseases such as hypertension, coronary heart diseases and arrhythmias etc., according to a press release from APL.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Ranbaxy gets US FDA approval for hypertension drug

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line